#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute myeloid leukaemia Oesophageal adenocarcinoma Kaposi's sarcoma Spina bifida Carcinoid tumour Retinoblastoma Chondrosarcoma metastatic Squamous cell carcinoma of head and neck Acute lymphocytic leukaemia Osteosarcoma recurrent Retinitis pigmentosa Chronic lymphocytic leukaemia recurrent Ovarian cancer Crohn's disease HER2 mutant non-small cell lung cancer More trials…

    Learn about Rare Diseases

    Adrenocortical carcinoma – Life with Disease Congenital nephrogenic diabetes insipidus – Basic Information Kearns-Sayre syndrome – Life with Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease Progressive multifocal leukoencephalopathy – Treatment Ewing’s sarcoma – Life with Disease Mitochondrial myopathy – Life with Disease KBG syndrome – Life with Disease Osteosarcoma metastatic – Life with Disease Angiosarcoma non-metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ascorbic Acid Sotatercept Pal1-15 Acetate SAR445399 Ucp4 Dextran 70 Rbl027.2 Talazoparib Botensilimab Rezvilutamide Mometasone Furoate Ph. Eur. GSKVX000000070248 Lisaftoclax Ads-011 Samuraciclib Interleukin-1 Lenacapavir Sodium Regn7257 CILOSTAZOL Tigecycline More therapies…

    Learn about Your Condition

    Renal cell carcinoma Small for dates baby Solitary fibrous tumour Lung adenocarcinoma stage III Combined immunodeficiency Prostate cancer metastatic Polymyositis Colon cancer stage III Malignant fibrous histiocytoma Lyme disease Metastasis Oral lichen planus Asthma Nervous system disorder Ovarian cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Children’s Health Medical Center EOOD

Children’s Health Medical Center EOOD

Ulitsa Maestro Kinev 2 A, Sofia, 1618, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • A Study of ACP-204 Tartrate for Adults With Lewy Body Dementia Psychosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dementia with Lewy bodies
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy

  • A Study Testing ACP-204 Tartrate Compared to Placebo for Adults with Lewy Body Dementia Psychosis

    Recruiting

    2 1
    Investigated Diseases:
    • Dementia with Lewy bodies
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy

  • Study of milsaperidone as an additional treatment for adults with Major Depressive Disorder who are already taking antidepressants

    Recruiting

    3 1
    Investigated Drugs:
    • (1S)-1-[4-[3-[4-(6-FLUORO-1,2-BENZOXAZOL-3-YL)PIPERIDIN-1-YL]PROPOXY]-3-METHOXYPHENYL]ETHANOL
    Bulgaria Czechia Poland

  • Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Budesonide
    • Formoterol Fumarate Dihydrate
    • Glycopyrronium Bromide
    Austria Bulgaria Czechia Denmark Finland France +10

  • A study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Austria Belgium Bulgaria Croatia Denmark Hungary +8

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!